Author

Roberto Salvia

When should we call the surgeon?
When should we call the surgeon?

Roberto Salvia

Multimodal treatment in resectable and locally advanced pancreatic cancer: Resection, pre-/postoperative chemotherapy, clinical relevance of ablation?
Multimodal treatment in resectable and locally advanced pancreatic cancer: Resection, pre-/postoperative chemotherapy, clinical relevance of ablation?

Roberto Salvia

SURVEILLANCE FOR PRESUMED BD-IPMN OF THE PANCREAS: STABILITY, SIZE, AND AGE IDENTIFY TARGETS FOR DISCONTINUATION
SURVEILLANCE FOR PRESUMED BD-IPMN OF THE PANCREAS: STABILITY, SIZE, AND AGE IDENTIFY TARGETS FOR DISCONTINUATION

Roberto Salvia  et al.

PANCREATIC RESECTIONS FOR CYSTIC NEOPLASMS: FROM SURGEON’S PRESUMPTION TO PATHOLOGIST’SREALITY
PANCREATIC RESECTIONS FOR CYSTIC NEOPLASMS: FROM SURGEON’S PRESUMPTION TO PATHOLOGIST’SREALITY

Roberto Salvia  et al.

ENDOSCOPIC ULTRASONOGRAPHY IS A GAME CHANGER IN PANCREATIC CYSTS MANAGEMENT: INTENTION-TO-TREAT ANALYSIS
ENDOSCOPIC ULTRASONOGRAPHY IS A GAME CHANGER IN PANCREATIC CYSTS MANAGEMENT: INTENTION-TO-TREAT ANALYSIS

Roberto Salvia  et al.

SYSTEMATIC REVIEW AND META-ANALYSIS OF OBSERVATIONAL STUDIES ON BD-IPMNS RISK OF PROGRESSION TO HIGH-RISK LESIONS
SYSTEMATIC REVIEW AND META-ANALYSIS OF OBSERVATIONAL STUDIES ON BD-IPMNS RISK OF PROGRESSION TO HIGH-RISK LESIONS

Roberto Salvia  et al.

SURGERY AFTER NEOADJUVANT THERAPY IS SUPERIOR TO UPFRONT SURGERY FOR PANCREATIC CANCER WITH VENOUS INVOLVEMENT
SURGERY AFTER NEOADJUVANT THERAPY IS SUPERIOR TO UPFRONT SURGERY FOR PANCREATIC CANCER WITH VENOUS INVOLVEMENT

Roberto Salvia  et al.

THE USE OF A MOBILE APPLICATION TO DISSEMINATE THE GUIDELINES ON CYSTIC NEOPLASMS OF THE PANCREAS: EM>A SNAPSHOT STUDY OF 1000 CASE-SIMULATIONS
THE USE OF A MOBILE APPLICATION TO DISSEMINATE THE GUIDELINES ON CYSTIC NEOPLASMS OF THE PANCREAS: EM>A SNAPSHOT STUDY OF 1000 CASE-SIMULATIONS

Roberto Salvia  et al.

DEFINING AND PREDICTING RECURRENCE IN PATIENTS UNDERGOING PANCREATECTOMY AFTER NEOADJUVANT TREATMENT FOR PANCREATIC DUCTAL ADENOCARCINOMA
DEFINING AND PREDICTING RECURRENCE IN PATIENTS UNDERGOING PANCREATECTOMY AFTER NEOADJUVANT TREATMENT FOR PANCREATIC DUCTAL ADENOCARCINOMA

Roberto Salvia  et al.

Item 1 - 9 / 9
1